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Background: The anatomy of the substantia nigra on conventional MRI is controversial. Even using histological
techniques it is difﬁcult to delineate with certainty from surrounding structures. We sought to deﬁne the anato-
my of the SN using high ﬁeld spin-echoMRI of pathological material inwhichwe could study the anatomy in de-
tail to corroborate our MRI ﬁndings in controls and Parkinson's disease and progressive supranuclear palsy.
Methods: 23 brains were selected from the Queen Square Brain Bank (10 controls, 8 progressive supranuclear
palsy, 5 Parkinson's disease) and imaged using high ﬁeld 9.4 Tesla spin-echo MRI. Subsequently brains were
cut and stained with Luxol fast blue, Perls stain, and immunohistochemistry for substance P and calbindin.
Once the anatomywas deﬁned onhistology the dimensions and volumeof the substantia nigrawere determined
on high ﬁeld magnetic resonance images.
Results: The anterior border of the substantia nigra was deﬁned by the crus cerebri. In the medial half it was less
distinct due to the deposition of iron and the interdigitation of whitematter and the substantia nigra. The poste-
rior border was ﬂanked by white matter bridging the red nucleus and substantia nigra and seen as hypointense
on spin-echo magnetic resonance images. Within the substantia nigra high signal structures corresponded to
conﬁrmed nigrosomes. These were still evident in Parkinson's disease but not in progressive supranuclear
palsy. The volume and dimensions of the substantia nigra were similar in Parkinson's disease and controls, but
reduced in progressive supranuclear palsy.
Conclusions: We present a histologically validated anatomical description of the substantia nigra on high ﬁeld
spin-echo high resolution magnetic resonance images and were able to delineate all ﬁve nigrosomes. In accor-
dancewith the pathological literaturewe did not observe changes in the nigrosome structure asmanifest by vol-
ume or signal characteristics within the substantia nigra in Parkinson's disease whereas in progressive
supranuclear palsy there was microarchitectural destruction.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The substantia nigra (SN) is located in the mesencephalon posterior
to the crus cerebri (CC) and anterior to the midbrain tegmentum and
comprised of two anatomically and functionally distinct parts: the infe-
rior and posterior SN pars compacta (SNc) containing pigmented
melanised neurons, and the superior and anterior (ventral) SN pars
reticulata (SNr). The dopaminergic neurons of the pars compacta project
via the nigrostriatal pathway to the striatum, and there is a reciprocal
striatonigral projection. The neurons of the SNr form one of the output
nuclei of the basal ganglia which along with the internal segment of
the globus pallidus project to the thalamus (Nieuwenhuys et al., 1988).
The striatonigral projection is commonly used to deﬁne the borders
of the SN by staining for substance P (SP) (Gibb, 1992; Mai et al., 1986;
McRitchie et al., 1995; McRitchie et al., 1996) or calbindin (CB)
(McRitchie et al., 1996; Damier et al., 1999a, b; McRitchie and
Halliday, 1995). Both antibodies label the neuropil and ﬁbres within
the SN rather than cell bodies with less immunoreactivity around
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clusters of pigmented cells (McRitchie et al., 1996; Damier et al., 1999a,
b). Calbindin staining is more intensely medially where occasional pos-
itive neurons within the SNc may be found (McRitchie and Halliday,
1995).
The internal anatomy of the SN is complex and various divisions
based on identiﬁable nuclear groups have been proposed (Gibb, 1992;
McRitchie et al., 1995; McRitchie et al., 1996; Damier et al., 1999a, b;
German et al., 1989; Fearnley and Lees, 1991; Gibb and Lees, 1991;
Hassler, 1937; Olzewski, 1954). Although 60% of pigmented neurons re-
side in the matrix these are sparsely distributed relative to the 40% of
densely packed neurons within well-deﬁned ‘nigrosomes’ (Damier et
al., 1999a). Nigrosome structure is maintained in the presence of
Parkinson's disease pathology (Damier et al., 1999b) but the ventrolat-
eral tier, or nigrosome 1 is most susceptible to neuronal loss in
Parkinson's disease (German et al., 1989; Damier et al., 1999b;
Fearnley and Lees, 1990; Hassler, 1938). Other neuronal groups may
be affected by age (dorsolateral tier, N4) and other neurodegenerative
diseases such as progressive supranuclear palsy (ventromedial tier)
(Fearnley and Lees, 1991).
The anatomy of the SN on conventional MRI is not well deﬁned
(Adachi et al., 1999; Gorell et al., 1995; Martin et al., 2008; Savoiardo
et al., 1994; Massey and Yousry, 2010). However, using high ﬁeld MRI
the SN is more clearly demarcated (Cho et al., 2011; Kwon et al.,
2012), and nigrosome 1 is visible in the dorsolateral substantia nigra
(Blazejewska et al., 2013) as the “swallow tail sign” which is lost in
Parkinson's disease (Schwarz et al., 2014) and other parkinsonian con-
ditions (Reiter et al., 2015).
Clinicopathological studies conﬁrm that even in the most experi-
enced hands Parkinson's disease and progressive supranuclear palsy
can be difﬁcult to diagnose accurately and reliable biomarkers are an
unmet need. The aim of this studywas to produce an accurate, validated
and detailed description of the anatomy of the SN based on histological
staining including immunohistochemistry and Perls stain of the same
tissue studied with high ﬁeld spin-echo MRI at 9.4 Tesla – so called
MRmicroscopy - and describe anatomical changes based on histological
ﬁndings in disease including Parkinson's disease and progressive
supranuclear palsy.
2. Materials and methods
Post-mortem brain tissue was obtained from the Queen Square
Brain Bank for Neurological Disorders (QSBB), UCL Institute of Neurolo-
gy, where tissue is donated according to ethically approved protocols
and is stored under a licence from the Human Tissue Authority. Brains
were sampled for histology using an established protocol
(Trojanowski and Revesz, 2007) and the diagnosis conﬁrmed using
standard neuropathological criteria (Ince et al., 2008).
2.1. Tissue preparation
Formalin-ﬁxed tissue was dissected to produce a tissue block to in-
clude the upper pons, entire midbrain with the substantia nigra and
ventral diencephalon. The MRI axis was aligned perpendicular to the
long axis of the brainstem and, after imaging the specimen was sliced
in approximately 5 mm thick tissue blocks along this midline sagittal
axis which were subsequently embedded in parafﬁn wax.
2.2. MRI protocol
Samples were imaged at room temperature in perﬂuoropolyether
(Fomblin, Solvay Selexis) at 9.4 T (Varian NMRS MRI) with a 40 mm
quadrature volume RF coil as previously described (Massey et al.,
2012b).
1. Parameters for high-resolution spin-echo (SE) images were: TE 15–
22 ms, TR 2000–2200 ms, scan averages 24–32, interleaved slices,
slice thickness 0.5–1 mm, slice gap 0.5–1 mm, matrix 512 × 512,
ﬁeld of view (FOV) 45 × 45mm (in-plane resolution 88 μm) and im-
aging time up to 10 h.
2. Superior in-plane resolution was obtained in one case: 1024 × 1024
matrix (in plane resolution 44 μm), 132 averages; other parameters
as above, imaging time 72 h.
These parameters were chosen on the basis of pilot acquisitions to
yield optimal image contrast for the structures of interest. Images
were viewed and processed in ImageJ (version 1.43h, US National Insti-
tutes of Health, Bethesda, Maryland) (Rasbrand, 2009).
2.3. Histological protocol
The parafﬁn wax embedded tissue blocks were serially sectioned at
20 μm. Every 20th section was stained with the Luxol fast blue and
Cresyl Violet (LFB/CV) method. MRI images and LFB/CV stained slides
were visually compared and once the best match between histology
and MRI was identiﬁed, neighbouring tissue sections were stained
with Perls stain for iron and used for immunohistochemistry with anti-
bodies to substance P (SP) and calbindin (CB). For immunohistochemis-
try sections were dewaxed, taken to absolute alcohol and blocked in
H2O2/methanol. For substance P immunohistochemistry tissue sections
were blocked in 10% normal swine serum for 10 min. Tissue sections
were incubated with the primary antibodies for 1 h at room tempera-
ture and then washed in PBS. Polyclonal antibodies were incubated in
swine anti rabbit 1:200 for 30 mins. Monoclonal antibodies were incu-
bated in rabbit anti mouse 1:200 for 30 mins and then washed in PBS.
All sections were incubated in Vector ABC for 30 mins and washed in
PBS. The colourwas developedwith glucose oxidase nickel dab solution.
Sections were counterstained in Mayer's haematoxylin and washed
dehydrated and mounted. The following antibodies were used: sub-
stance P (Invitrogen Polyclonal; 1:50); calbindin (Abcam Monoclonal;
1:400). Macroscopic images were obtained at 20–40× magniﬁcation
using Image Pro Plus (Mediacybernetics, Bethesda, MD www.mediacy.
com) andmicroscopic images using Leica biosystems digital image hub.
2.4. Image segmentation
MR images were segmented manually in ITK-SNAP (version 1.8.0)
(Yushkevich et al., 2006). Reconstructions were made using the mesh
function, andmeasurement of volumewas performed onmanually seg-
mented regions. Linear measurements of SN breadth and width were
performed in Image J.
2.5. Analysis
The anatomy of the SN was demonstrated in a single case with LFB/
CV, Perls stain, SP and CB immunohistochemistry and high ﬁeld SE MR
microscopy at multiple serial axial levels through the SN. The anatomy
was deﬁned by overlying LFB/CV, SP, CB, Perls and SE MRI images
level by level. A cartoon of the anatomy was developed to conﬁrm the
borders and internal anatomy of the SN. Once the anatomywas demon-
strated the volume, dimensions and variability in borders, landmarks
and internal anatomy was studied in control and disease cases
(Parkinson's disease, progressive supranuclear palsy) at the level of
the exit of the IIIrd cranial nerve and RN which is the most studied
level in the pathological and radiological literature.
3. Results
3.1. Characteristics of cases studies
Twenty three caseswere included in the study including 10 controls,
8 progressive supranuclear palsy and 5 Parkinson's disease [Table 1].
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3.2. Deﬁning the anatomy of the SN on SE MRI
The substantia nigra as deﬁned by SP and CB immunohistochemistry
was studied from the level of the STN [level 1] to the level of the
brachium conjunctivum [level 7] in serial 0.5 mm thick axial sections
spaced by 1.0 mm [Fig. 1A–E].
3.2.1. Borders
3.2.1.1. Anterior border. The anterior SN was bordered by the crus
cerebri.
3.2.1.1.1. LFB/CV. The border was clear except superior and medially
[Fig. 1B levels 1&2] where there were ‘interdigitations’ of blue-staining
myelinated ﬁbres and regions of low LFB/CV staining [Fig. 2A&B]. In
the most medial portion there is white matter clustering which has
the appearance of a ‘hook’ (see below) [Fig. 1B levels 2–4]. On the lateral
border encroaching into the SN there is amyelinated clusterwhichhas a
triangular shape (anteromedial (AM) white matter see below) [Fig. 1B
levels 2–5].
3.2.1.1.2. Perls. There is staining throughout the anterior border but
particularly anteromedially [Fig. 1C all levels]. This encroached on the
myelinated ﬁbres of the corticospinal tracts and AM [Fig. 2B&E] (see
below).
3.2.1.1.3. Immunohistochemistry. SP immunostain deﬁnes the anteri-
or border by staining the striatonigral innervating ﬁbres and is in
agreement with the LFB/CV stain with ﬁbres seen radiating into the CC
[Figs. 1E, 2C&F]. This gives rise to a linear appearance which interdigi-
tates with the crus cerebri [Fig. 1E levels 1–3]. CB also has a serrated ap-
pearance at this level but gives a more uniform appearancewith denser
staining medially.
3.2.1.1.4. Spin-echo MRI. The medial part of the anterior border is
more diffuse but lacks the interdigitating/serrated appearance of the
anatomical and immunocytochemistry [Fig. 1D levels 1–7]. There is a
hypointense rim (HR) which corresponds to the anterior border but is
more prominent superomedially.
3.2.1.2. Posterior border. The posterior border of the SN is somewhat con-
troversial in the literature. Using SP immunohistochemistry the
parabrachial nucleus (Halliday, 2004) or gamma group of Olzewski
(Olzewski, 1954) are excluded and this deﬁnition has been used for
this study.
3.2.1.2.1. LFB/CV. The posterior border is deﬁned bymyelinated ﬁbres
which appear to run in a posterolateral to anteromedial axis (Adachi et
al., 1999; Gorell et al., 1995) seen at superior levels separating the SN
from the STN [Fig. 1B level 1] or the RN/BC [Fig. 1B level 2–7]. Laterally
at lower levels this is formed by the medial lemniscus (ML) which is
more heavily myelinated [Fig. 1B level 6–7]. At mid-levels there is a
small group of myelinated ﬁbres which we have termed posterolateral
white matter (PL) [Fig. 1B levels 2–5]. The medial posterior border is
less clearly deﬁned but at its most medial aspect is bounded by ﬁbres
of the third nerve in the mid-level section [Fig. 1B level 5].
3.2.1.2.2. Perls. At the most superior levels Perls stain for iron reveals
dense staining on the medial posterior border [Fig. 1C level 1]. Below
this relatively less iron is deposited in the posterior border than the an-
terior border of the SN [Fig. 1C levels 2–5] until at the lower levels there
is more intense Perls staining particularly medially [Fig. 1C levels 6–7].
3.2.1.2.3. Immunohistochemistry. SP immunostain deﬁnes the border
in correspondence with LFB/CV except in the mid levels lateral portion
where there is a small posterior protrusion not seen on LFB/CV [Fig. 1E
levels 3–4 arrowed]. CB stains as per LFB/CV although themedial-lateral
gradient makes the lateral portion less evident.
3.2.1.2.4. Spin-echo MRI. At the most superior level a hypointense
band (HB) separates the STN and SN [Fig. 1D level 1] (Massey et al.,
2012a, b). At lower levels the border is deﬁned by a high signal intensity
band. At mid levels it is less clear andmedially comprised of both a thin
high intensity band adjacent to the RN a region of hypointensity border-
ing on the relative hyperintensity of the SN itself. At lower levels the
hypointense band is more prominent corresponding to the increased
Perls staining and the border is formed by a hyperintense band separat-
ing the SN from the ML laterally [Fig. 1C&D levels 6–7].
3.2.1.3. Lateral border
3.2.1.3.1. LFB/CV. The lateral border of the SN is bounded by the crus
cerebri wrapping around the SN [Fig. 1B level 1–4] and the abutting of
the CC and ML at lower levels [Fig. 1B level 5–7].
3.2.1.3.2. Perls. There is less iron staining at themost lateral portion of
the border of the SN than medially but it is still evident at the most lat-
eral portion.
3.2.1.3.3. Immunohistochemistry. The border is clearly deﬁned al-
though less so on CB than SP immunohistochemical preparation due
to the medial-lateral gradient.
3.2.1.3.4. Spin-echo MRI. The border is clearly deﬁned corresponding
to the distribution of myelinated ﬁbres with some iron on the anterior
aspect of the lateral border.
3.2.1.4. Medial border. This is most clearly deﬁned at the level of the exit
of the fascicles of the third nerve.
3.2.1.4.1. LFB/CV.At levelswhere fascicles of the third nerve are found
this deﬁnes the medial border [Fig. 1 level 5]. At other levels the medial
border is determined by the medial edge of the tissue specimen.
3.2.1.4.2. Perls. The anterior medial SN has high iron staining.
3.2.1.4.3. Immunohistochemistry. These preparations clearly deﬁne a
medial border.
3.2.1.4.4. Spin-echo MRI. The medial border is deﬁned by a hyper in-
tense rim formed by the bundles containing fascicles of the third
nerve [Fig. 1 level 5].
Table 1
Characteristics of cases imaged using high ﬁeld MR microscopy.
No Gender Side
ﬁxed
Age DOF
(days)
Category Pathological diagnosis
1 F Both 94 4149 Control n/a
2a M right 94 51 Control Small vessel disease (severe),
Braak & Braak stage IV
3a M right 38 56 Control Minimal abeta deposition
4a M left 78 78 Control CAA (moderate)
5 M both 79 1029 Control Pathological ageing, mild cvd
6 F Left 82 366 Control Pathological ageing, mild svd,
mod CAA
7 F Right 82 302 Control Pathological ageing, right parietal
infarct
8 F Right 72 67 Control MND
9 F Right 99 26 Control B&B IV NFT pathology
10 M Left 89 18 Control n/a
11a M Left 68 54 PSP PSP, Lewy body pathology,
pathological ageing
12a M Right 69 89 PSP PSP, pathological ageing
13 M Right 66 315 PSP PSP
14 M Right 86 165 PSP PSP, pathological ageing, small
haemorrhagic frontal focus
15 M Whole 68 88 PSP PSP, pathological ageing
16 M Right 71 51 PSP PSP
17 F Right 75 85 PSP PSP
18 M Left 67 51 PSP PSP, acute MCA infarct
19a M Left 79 260 PD PD
20a M Right 83 28 PD PD
21 M Right 70 31 PD PD, limbic Lewy body pathology
22 F Left 62 45 PD PD, neocortical Lewy body
pathology
23 M Left 71 31 PD PD, limbic Lewy body pathology,
neocortical Lewy body pathology,
pathological ageing, mild CAA,
focal hippocampal infarction
a These cases had Luxol fast blue, immunohistochemistry and Perl stain for comparison.
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3.2.2. Three useful landmarks
We identiﬁed three internal landmarks within the SN:
1. Anterior Medial White Matter (AM): in the anterior and medial SN
there are myelinated ﬁbres appearing in the shape of a ‘hook’ (H)
[Fig. 1A&B levels 1–6]. Clusters of fascicles of WM staining blue on
LFB/CV and with Perls stain are seen within the SN indicating that
they are a site of iron deposition. [Fig. 1C levels 1–6]. On spin-echo
MRI there is corresponding signal hypointensity [Fig. 1D levels 1–
6]. Higher ﬁeld images demonstrate Perls staining as both pigment
in the neuropil and in clusters of white matter [Fig. 2B&E].
2. Anterior Lateral White Matter (AL): in the anterolateral portion of
the SN there is a triangular region containing myelinated ﬁbres
[Fig. 1B levels 2–5]. These ﬁbres have higher Perls staining [Fig. 1C
levels 2–5] and are seen as hypointense on MRI [Fig. 1D levels 2–5].
3. Posterior Lateral White Matter (PL): in the posterolateral SN there
are myelinated ﬁbres found just medial to the medial border of the
SN [Fig. 1A&B levels 2–5]. At the most inferior levels these corre-
spond to the medial lemniscus [Fig. 1B levels 6–7]. In contrast to
the AL these donot appear to stain strongly for iron but are still signal
hypointense [Fig. 1D levels 2–5] on SE MRI.
3.2.3. Substantia nigra pars reticularis (SNr)
The SNr was found anteriorly and superiorly to the SNc [Fig. 1A
levels 1–3] and was thus more clearly visualised at superior levels -
Fig. 1. The Anatomy of the SN on serial axial sections using Luxol fast blue/Cresyl Violet (LFB/CV), Perls stain, high ﬁeld spin-echo MRI, and substance P (SP) and calbindin (CB)
immunohistochemistry. Case 2 was a 36 yr old male. Serial axial sections at 1.5 mm through a single substantia nigra (SN) A: cartoon showing key anatomical structures based on SP
and LFB/CV for borders, LFB/CV for location of pigmented neurons on substantia nigra pars compacta (SNc) and CB for nigrosomes. Pigmented neurons are shown as black dots and it
is notable that not all of these fall within the CB-deﬁned nigrosomes. B: LFB/CV. C: Perls stain. D: High ﬁeld spin-echo MRI. E: SP. F: CB. Anatomical landmarks are in black. Nigrosomes
(1–5) are labelled in red. See text for a detailed description of the anatomy and comparison of images. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
Fig. 2. The anteromedial border of the substantia nigra at superior levels. A–C 10×
magniﬁcation; D–F 2× magniﬁcation. A & D Luxol fast blue/Cresyl Violet (LFB/CV), B & E
Perls stain, C & F substance P (SP) immunohistochemistry. G High ﬁeld spin-echo MRI
image show region represented by histological sections. Lower and higher ﬁeld
histological sections using LFB/CV and SP show the interdigitation of white matter with
the anteromedial border of the SN. Perls stain can be seen blurring the boundary of the
SN in B & E and appears to stain both white matter in the border and within the anterior
SN itself - the anteromedial white matter (AM) landmark - see text.
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pigmented cells were found from level 2–7 [Fig. 1A levels 2–7]. It is de-
ﬁned by non-pigmented cells on the LFB/CV preparation [Fig. 3]. It cor-
responds topographically to the region of strong iron staining anteriorly
and medially at more superior levels [Fig. 1]. On high ﬁeld spin-echo
MRI it appears heterogeneously with a hypointense rim (HR) and rela-
tively hyperintense core, and is not immediately distinguishable from
the SNc using SP or CB immunohistochemistry or by signal characteris-
tics on spin-echo MRI.
3.2.4. Substantia nigra pars compacta (SNc) internal anatomy
The SNc is deﬁned by the presence of cells containing neuromelanin
pigment [Fig. 1A all levels & Fig. 3]. These are visible on the LFB/CV and
Perls stained sections and can be deﬁned by location (Hassler, 1937;
Gibb et al., 1990) or by using calbindin immunohistochemistry to delin-
eate so-called ‘nigrosomes’ where there is relatively reduced calbindin
staining of the neuropil (Damier et al., 1999a) [Fig. 1A&E levels 2–7;
Fig. 3]. Not all pigmented cells are found in nigrosomes (Damier et al.,
1999a) and this is demonstrated in the Cartoon [Fig. 1A levels 2–7].
On Perls stain there is less intense staining within the nigrosomes, par-
ticularly seen at lower levels [Fig. 1C levels 4–7] and Perls staining is less
intense in nigrosomes [Fig. 1C level 6 & 7].
Nigrosome 1 (N1 - the ‘ventrolateral tier’) was seen in levels 3–7. It
was closely apposed to the posterior border of AL [Fig. 1A&E levels 3–5]
and formed a solitary band in lower levels [Fig. 1A&E levels 6–7]. On
spin-echo MRI it appears as a hyperintense band radiating across from
the posterolateral border towards the anteromedial border deﬁned by
hypointensity of the AL on the anterior border and a hypointense
band on the posterior border particularly medially where the ‘hook’
formed by the AM was seen [Fig. 1A&D levels 3–7].
Nigrosome 2 (N2 - the pars medialis) was seen at all levels where
pigmented cells were found [Fig. 1A&E levels 2–7] at the most posterior
and medial tip of the SN. This was not so clearly seen on spin-echo MRI.
There is relative signal hyperintensity at the most medial and posterior
tip but this does not directly correspond to the size and shape of the
region identiﬁed by calbindin immunohistochemistry, although the clus-
ter of pigmented cells clearly extends beyond this region [Fig. 1A&E all
levels].
Nigrosome 3 (N3 - the ‘pars lateralis’) was seen in levels 4–6. It is
bounded by the AL and the CC as it wraps around the lateral border of
the SN [Fig. 1A&B levels 3–5]. N3 was identiﬁed on spin-echo MRI by
signal hyperintensity bounded by the low signal intensity of AL and
the CC [Fig. 1A&D levels 3–5].
Nigrosome 4 (N4 - the ‘dorsolateral tier’) was seen in levels 3 & 4. It
abutted the posterior border of the SN and the PL [Fig. 1 levels 3&4]. On
spin-echo MRI it appeared as a hyperintense band posterior to N1 and
bounded by the signal hypointensity of the parabrachial nucleus imme-
diately adjacent.
Nigrosome 5 (N5) was found at the most superior level where
pigmented cells were found only [Fig. 1A&E level 2]. This was seen on
conventional MRI as a region of signal hyperintensity between the AL
and PL.
On spin-echo MRI N1 and N4 in the lateral SNc give the appearance
of a spin-echo signal hyperintense ‘pincer’ grasping a spin-echo signal
hypointense ‘hook’ corresponding to the Perls staining AM.
3.2.5. Sagittal and coronal plane images
In case 8 sagittal and coronal high ﬁeldMRI imageswere available. In
the sagittal plane the superoposterior border of the SN is separated from
the STN by a thin hypointense rim (HR); inferiorly spin-echo MRI hy-
perintense signal white matter separates it from the RN including the
region of the parabrachial nucleus. The inferoanterior border of the SN
abuts the CC along the entire length of the nucleus [Fig. 4A–H].
In the coronal plane the superomedial border is deﬁned by a
hypointense rim (HR) separating it from the STN in the superior half;
in the inferior half it is separated from the RN by the spin-echo MRI hy-
perintense signal white matter. The inferolateral border is formed by
the CC in the entire length of the SN [Fig. 4I–P].
3.2.6. Location, position and relations using spin-echo MRI
The SN was clearly identiﬁed in all 10 control cases studied (11 half
brains). It was found in the anterior portion of themidbrain posterior to
the CC and anterior to the STN, RN and DSCP. It lay at an oblique angle in
all three planes: in the axial plane the SN was approximately 40° from
the midline at the level of the STN and RN, and 30° at the level of the
DSCP; on sagittal images it lay at 35° and in coronal images 45°with ref-
erence to the axis of the brainstem; on these latter two images the SN
was seen to lie mostly inferior and lateral to the RN and encase the
STN's inferolateral aspect.
3.3. Comparison of the SN between controls, Parkinson's disease and pro-
gressive supranuclear palsy
3.3.1. Volume and dimensions
The mean volume of the SN was 211.3 mm3 in controls, 120.8 mm3
in progressive supranuclear palsy and 180.8mm3 in Parkinson's disease.
In progressive supranuclear palsy the volumewas signiﬁcantly reduced
compared to controls (p b 0.001) and Parkinson's disease (p = 0.008),
but there was no signiﬁcant difference between Parkinson's disease
and controls [Table 1]. The SN is most broad and deep at the level of
the RN (mean width 11.72 mm; mean depth 2.99 mm), tapering at
the superior extremity and resembling a tear in the sagittal and coronal
planes [Fig. 4]. Maximal length in the sagittal plane was 14.0 mmand in
the coronal plane 14.4 mm. In progressive supranuclear palsy depth at
the level of the RN and DSCP and width at the level of the RN were re-
duced in progressive supranuclear palsy [Table 1] but not in Parkinson's
disease.
3.3.2. Borders at the level of the RN
The anterior border wasmore clearly deﬁned laterally with haziness
in themedial sectionwith heavy deposition of iron andWM, SP+ ﬁbres
Fig. 3. The internal anatomy of the substantia nigra (SN) using Luxol fast blue/Cresyl Violet
(LFB/CV) and calbindin (CB) immunohistochemistry. LFB/CV and CB stains delineating the
anatomy of the nigrosomes within the SN at axial levels as per Fig. 1. At the superior level
(2) anterior and medial SN represents a regions without neuromelanin containing
neurons and is the substantia nigra pars reticulata (SNr). At the lower levels represented
(3, 5, 6) clusters of neurons are seen both on LFB/CV and CB immunohistochemistry. On
CB stain regions of relative CB-poor stain are designated nigrosomes (Damier et al.,
1999a, b).
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invaginating into the CC in controls, Parkinson's disease and progressive
supranuclear palsy [Figs. 2, 5; Table 2]. This was also true on spin-echo
MRI in controls and Parkinson's disease [Figs. 1, 5] although in progres-
sive supranuclear palsy [Fig. 5] in some cases the lateral border was less
distinct [Table 3].
The posterior border was deﬁned by white matter of the PBNmedi-
ally and laterally by PL on histology in control and disease cases [Table 2]
and on spin-echo MRI [Table 3].
The medial border was clearly deﬁned in all cases by fascicles of the
IIIrd nerve and the medial CC and the lateral border was deﬁned by the
CC.
3.3.3. Landmarks at the level of the RN
AM, AL and PLwere seen in all control and Parkinson's disease SNs at
this level on histology and spin-echo MRI, but were less frequent in the
progressive supranuclear palsy group, particularly PL which was only
seen in 1/8 progressive supranuclear palsy SNs [Table 3].
3.3.4. Internal anatomy at the level of the RN
Overall and in keepingwith the volumemeasurements [Table 1] the
SN appears similar in controls and Parkinson's disease [Figs. 1, 5] but is
markedly thinned in progressive supranuclear palsy [Fig. 5]. On histolo-
gy N1, N3 and N4were clearly visible andwere associatedwith reduced
Perls stain,whereasN2was associatedwith increased Perls stain in con-
trols. In the disease group the nigrosomes weremuch less densely pop-
ulated with pigmented neurons in Parkinson's disease [Fig. 5] [Table 2].
In Parkinson's disease the nigrosomes looked thick and pale [Fig. 5]; in
progressive supranuclear palsy thin and streaky with dense Perls stain-
ing [Fig. 5]. On spin-echoMRI, nigrosomeswere paler in Parkinson's dis-
ease but still mostly identiﬁable [Fig. 5; Table 3], and in progressive
supranuclear palsy were more difﬁcult to identify and had a stringy/
streaky appearance when seen [Fig. 5] [Table 3].
4. Discussion
We have demonstrated the anatomy of the SN using high ﬁeld spin-
echo MRI at 9.4 T and validated this by comparison with stained sections
in the same post-mortem tissue. The anterior border of the SN was more
clearly delineated laterally and inferiorly whereas there is blurring of the
margins between the SN and CC, particularly anteriorly and medially at
the most superior levels characterised by higher iron deposition on
Perls staining and a serrated edge on SP immunohistochemistry. The pos-
terior border is formed by white matter lying between the SN and RN in
the medial aspect and the SL and ML in the lateral aspect and is mostly
hypointense. The hyperintense band described in the literature is more
posterior, abutting the RN and forms part of the PBN [Fig. 1B&D levels
3–5]. We have also described three white matter bundles deﬁned by
their anatomical position (AM, AL and PL) which are seen on high ﬁeld
MRI and are useful landmarks in the SN.
Within the SN itself there is heterogeneous signal. The region of
the SNr is hypointense on spin-echo MRI with a hypointense rim de-
ﬁning its anterior border, and a hypointense band deﬁning its poste-
rior border from the STN. By using immunohistochemistry for CB we
are able to accurately locate Damier's nigrosomes (Damier et al.,
1999a). These are seen on high ﬁeld spin-echo MRI as hyperintense
regions whose position can be clariﬁed by reference to the white
matter landmarks AM, AL and PL. In controls the AM white matter
landmark forms a hypointense hook appearance, and the combina-
tion of high signal from N1 and N4 at the level of the RN and IIIrd
nerve fascicles gives a hyperintense ‘pincer’ appearance - similar to
the ‘swallow tail’ appearance described using SWI in vivo (Schwarz
et al., 2014) - which is bordered by the relatively hypointense AL
white matter dorsally to N1. Perls stain conﬁrms that the nigrosomes
are relatively low in iron compared the immediate environs [Fig. 1]
(Blazejewska et al., 2013).
Fig. 4. Sagittal and coronal views using highﬁeld spin-echoMRI. A–HSerial sagittal views at 1mmfrommedial to lateral. Substantia nigra (SN) inferior and anterior to the red nucleus (RN)
medially, and to the subthalamic nucleus (STN) laterally. I–P Serial coronal views at 1mm from anterior to posterior. The SN is inferior and tilted to the STN anteriorly and RN posteriorly.
The crus cerebri (CC) forms the anterior border. Signal hypointensity is greatermoremedially (B–D)and anteriorly (I–L)within the SN. Ahypointense band (HB) is seen separating the STN
from the SN in both the sagittal (F) and coronal planes (L).
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We found no difference in SN volume between controls and
Parkinson's disease, but in progressive supranuclear palsy the volume
was markedly reduced [Table 1]. This was in accord with the markedly
thinned appearance of the SN in axial sections on MRI and pathology
and increased Perls staining for iron [Fig. 5]. In Parkinson's disease the
white matter landmarks and nigrosomes were still visible although
the latter appeared less clearly deﬁned; in progressive supranuclear
palsy the topographical destruction was far greater. The undulation of
the anterior border of the SN reported by Kwon et al. (2012) does not
have an obvious pathological correlate particularly given that this is to-
pographically likely to be part of the SNr as it is found in themost ante-
rior and medial part of the whole SN.
Fig. 5. The anatomy of the SN in control, Parkinson's disease and progressive supranuclear palsy cases: A: Luxol fast blue/Cresyl Violet (LFB/CV). B: Perls stain. C: High ﬁeld spin-echoMRI.
D: Substance P (SP) immunohistochemistry. [1] 94 yr old control male just above the exit of the IIIrd nerve. [2] 94 yr old control male at the level of the exit of the IIIrd nerve fascicles. The
pigmented neurons of nigrosome 1 (N1) are clearly seenwithin a region of reduced Perls staining and as a hyperintense band on Spin-EchoMRI. The pincer and hook are clearly visualised,
and the white matter landmarks (anteromedial) AM, (anterolateral) AL and (posterolateral) PL. [3] 79 yr old male with Parkinson's disease. Borders and white matter landmarks are
present and subjectively and objectively does not appear to have lost volume [Table 2]. Spin-echo MRI shows a high intensity band consistent with N1 when compared with control
images. However, the remaining neuromelanin containing neurons are not within this structure. [4] 68 yr old male with progressive supranuclear palsy. The whole structure is
markedly atrophic as exempliﬁed by the reduced volume measurements and the reduced width and depth measurements [Table 2]. The borders, white matter landmarks and internal
structure is much less distinct.
Table 2
Anatomy of substantia nigra pars compacta (SNc) at level of red nucleus (RN) and exiting IIIrd nerve fascicles on histopathology.
SNc at the level of the RN and IIIrd nerve exit Control PSP PD
Histopathology LFB Perl PV LFB Perl PV LFB Perl PV
Borders Anterior Medial blurring 3/3 3/3 3/3 2/2 2/2 2/2 2/2 2/2 2/2
Lateral clarity 3/3 3/3 3/3 2/2 2/2 2/2 2/2 2/2 2/2
Posterior TMF 3/3 Mild 3/3 0/3 1/2 Mild 1/2 0/2 2/2 0/2 0/2
ML 3/3 0/3 0/3 2/2 0/2 1/2 extn 2/2 0/2 0/2
Medial III 3/3 0/3 0/3 2/2 0/2 0/2 2/2 0/2 0/2
Lateral CC 3/3 3/3 3/3
Landmarks AM 3/3 2/3 2/3 hypo 2/2 2/2 Hypo 2/2 2/2 2/2 hypo
AL 3/3 3/3 3/3 hypo 2/2 2/2 Hypo 2/2 2/2 Hypo
PL 3/3 1/3 3/3 2/2 2/2 Hypo 2/2 2/2 Hypo
Internal anatomy N1 3/3 3/3 hypo Sparse/absent Hyper++ 2/2 Absent 2/2 hypo
N2 2/3 2/3 hyper Sparse/absent Hyper++ 2/2 Sparse/absent 2/2 hyper
N3 3/3 2/3 hypo Sparse/absent Hypo Absent 2/2 hypo
N4 3/3 3/3 hypo Sparse/absent Hyper++ 2/2 Sparse/absent 2/2 hypo
N5
Pincer 3/3 3/3 hypo 0/2 0/2 0/2 2/2
Hook 3/3 2/3 hyper 1/2 0/2 2/2 2/2
Comments Thin, streaky, high Perl stain Thick, pale nigrosomes
160 L.A. Massey et al. / NeuroImage: Clinical 13 (2017) 154–163
Use of post-mortem pathological specimens validates our ﬁndings
on high ﬁeld spin-echoMRI whichwas obtainedwithoutmovement ar-
tifacts and time or tolerability constraints which limit in vivo acquisi-
tions. However, the MRI characteristics including relaxation times of
ﬁxed post-mortem tissue at room temperature are different to those
at body temperature in vivo and ﬁxation leads to asymmetric tissue
shrinkage (Quester and Schroder, 1997).
The anatomy of the SN is highly complex and as can be seen from the
serial axial sections [Fig. 1] it varies in its cross sectional dimensions and
the internal organisation throughout its course. Even the angle of histo-
logical sectioning may alter the appreciated anatomy (Gibb, 1992;
McRitchie et al., 1995; McRitchie et al., 1996; Damier et al., 1999a, b;
German et al., 1989; Fearnley and Lees, 1991; Gibb and Lees, 1991;
Hassler, 1937; Olzewski, 1954). Currently, conventional imaging tech-
niques are too insensitive to these subtleties possibly explaining the
heterogeneity of published work (Adachi et al., 1999; Gorell et al.,
1995; Martin et al., 2008; Savoiardo et al., 1994; Massey and Yousry,
2010), with pathological conﬁrmation the exception rather than rule
(Blazejewska et al., 2013; Oikawa et al., 2002). Many early studies
have been based on a presumed understanding of the anatomy on con-
ventional MRI (Duguid et al., 1986, Drayer, 1988a, b, Rutledge et al.,
1987, Pujol et al., 1992) (for review see Massey and Yousry, 2010).
High resolution 3 T imaging sensitive to the paramagnetic effects of
neuromelanin shows signal hyperintensity in the SN (Sasaki et al.,
2006).Multishot diffusion-weightedMR imagingwith a left to right dif-
fusion direction gradient may better deﬁne the borders of the SN than
T2w imaging (Adachi et al., 1999). Other published techniques to delin-
eate the SN include T1 weighted techniques (Menke et al., 2009),
relaxometry (Gorell et al., 1995; Martin et al., 2008; Ordidge et al.,
1994; Peran et al., 2010), segmented inversion recovery imaging
(Hutchinson et al., 2003; Raff et al., 2006), T2w and T2*-weighted tech-
niques (Eapen et al., 2011), susceptibility weighted imaging (SWI)
(Abosch et al., 2010) and magnetisation transfer ratio imaging (Helms
et al., 2009).
More recent in vivowork at 7.0 T has improved the resolution, con-
trast and signal-to-noise ratio using T2* (Cho et al., 2011; Kwon et al.,
2012) and at 3.0 T in vivo the swallow tail sign has been found to be a
reliably identiﬁable feature in the dorsolateral SN (Schwarz et al.,
2014; Reiter et al., 2015). However, caution is still required in
interpreting imaging even at 3.0 T - the resolution of in vivo images re-
mains below that required for accurate discrimination of these subdivi-
sions in the SN. Diffusion tensor imaging has been shown to be both
highly sensitive and speciﬁc for Parkinson's disease (Vaillancourt et al.,
2009), and to demonstrate age-appropriate changes (Vaillancourt et
al., 2012), although these ﬁndings have not been corroborated
(Schwarz et al., 2013).
CB immunohistochemistry has enabled us to deﬁne nigrosomes on
our histological sections (Damier et al., 1999a) with all 5 nigrosomes
seen in serial axial MR images [Fig. 1]. We do not appear to be imaging
the pigmented neurons themselves - when they are absent in
Parkinson's disease the spin-echo MRI hyperintensity remains [Fig. 5].
This is in keeping with pathological work where the nigrosome struc-
ture is maintained even in the face of loss of pigmented SNc cells
(Damier et al., 1999a, b). Many studies have tried to detect differences
in the traditionally-deﬁned SNc (Duguid et al., 1986) using conventional
MRI. There are reports of reducedwidth (Duguid et al., 1986; Pujol et al.,
1992; Braffman et al., 1989; Stern et al., 1989; Yagishita and Oda, 1996)
or smudging of the SNr hypointensity (Savoiardo et al., 1994; Drayer,
1988a, b; Savoiardo et al., 1989; Savoiardo et al., 1990). However, only
one study has found a correlation between the width of the SNc and a
measure of clinical severity (Pujol et al., 1992).
Usingmultishot diffusion-weightedMRI to deﬁne the borders of the
SN more clearly also did not show a reduced SN width in Parkinson's
disease (Adachi et al., 1999), and there were similar ﬁndings using dif-
fusion-weighted or fast STIR images (Oikawa et al., 2002). However,
this is not greatly surprising as although there is loss of
neuromelanin-containing pigmented cells in the SNc in Parkinson's dis-
ease (Fearnley and Lees, 1991;Ma et al., 1997;Hardmanet al., 1997) the
pathological literature supports the fact that the volume of the SN does
not reduce in Parkinson's disease (Ma et al., 1997). In fact, pathological
data in ageing (Cabello et al., 2002) and a recent imaging study in
Parkinson's disease (Kwon et al., 2012) even suggest that it may para-
doxically increase in size. Our data support this idea - both in terms of
the absolute measured volume not being signiﬁcantly different from
controls in Parkinson's disease [Table 2], and in the appearance of the
SN in the axial plane having preserved width and depth both subjec-
tively [Fig. 5] and quantitatively [Table 2]. Although there has already
been some success in detecting the regional distribution of pathology
in the SN in Parkinson's disease using techniques sensitive to micro-
scopic changes such as DTI (Peran et al., 2010; Vaillancourt et al.,
2009; Chan et al., 2007) in agreementwith the pathological topography
(Fearnley and Lees, 1991), subsequent studies have not conﬁrmed this
(Menke et al., 2009).
In progressive supranuclear palsy far greater destruction of the bor-
ders and internal architecture of the SN is found with loss of the
nigrosomal spin-echo MRI hyperintensity [Fig. 5, Tables 2 & 3]. This is
manifest as a reduced volume which is consistent with both the patho-
logical literature where progressive supranuclear palsy affects both SNr
and SNc (Hardman et al., 1997; Oyanagi et al., 2001), and imaging liter-
ature where a smaller SN has been described usingmultishot diffusion-
weighted imaging (Adachi et al., 1999). Many conventional MRI abnor-
malities have been described in the SN in progressive supranuclear
palsy but none are of clinical utility currently (Massey et al., 2012a).
There remain many unanswered questions that will inform future
research: there is very little information about the heterogeneity of
iron deposition in the body and anterior border of the SN and theprecise
location of the iron, or its role in the pathogenesis. The precise anatom-
ical correlate of signal hyperintensity on spin-echo MRI in the region of
the nigrosomes is not clear but it appears not to be the pigmented neu-
rons of the SNc as already discussed. The bestmethod to study the anat-
omy of the SN is also unclear - iron is clearly important in the
pathogenesis and so iron-sensitive techniques such as T2*-weighted
MRI and SWI should be employed but we have shown that iron strays
Table 3
Anatomy of substantia nigra pars compacta (SNc) at level of red nucleus (RN) and exiting
IIIrd nerve fascicles on high ﬁeld spin-echo MRI. Case 1 never had pathological examina-
tion and so was excluded from this part of the analysis.
SNc at the level of the RN and IIIrd
nerve exit
Control PSP PD
SE MRI images LFB SE
MRI
LFB SE MRI LFB SE
MRI
Borders Anterior Medial
blurring
9/9 9/9 8/8 8/8 5/5 5/5
Lateral
clarity
9/9 9/9 7/8 6/8 4/5 5/5
Posterior TMF 7/9 7/9 3/8 7/8 4/5 5/5
ML 9/9 9/9 8/8 8/8 4/5 5/5
Medial III 9/9 9/9 8/8 8/8 4/5 5/5
Lateral CC 8/9 8/9 8/8 8/8 4/5 5/5
Landmarks AM 7/9 8/9 7/8 5/8 4/5 4/5
AL 9/9 9/9 8/8 5/8 5/5 5/5
PL 9/9 8/9 6/8 1/8 5/5 5/5
Internal
anatomy
N1 9/9 9/9 6/8
sparse
2/8
stringy
0/5 5/5
faint
N2 9/9 0/9 6/8
sparse
0/8 4/5
sparse
0/5
N3 9/9 7/9 6/8
sparse
1/8 3/5
sparse
3/5
faint
N4 8/9 8/9 4/8
sparse
4/8
stringy
4/5
sparse
5/5
faint
N5
Pincer 9/9 9/9 0/8 3/8 0/5 4/5
Hook 6/9 9/9 5/8 2/8 5/5 5/5
Comments
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outside the SN proper and therefore these methods may be misleading.
Further studies are needed to answer some of these questions which in
the absence of SNmorphological changes in Parkinson's disease, will re-
quire quantitative MRI techniques such as relaxometry, DTI and MTI
with higher than currently commonly available in-plane resolution,
with correlative histopathological work.
We have demonstrated the anatomy of the SN histologically and ap-
plied this knowledge to understand the complex and heterogeneous
high ﬁeld spin-echo MRI SN appearance in the same tissue. We have
demonstrated the visibility of the nigrosomes using this technique and
the preservation of N1 in Parkinson's disease but not progressive
supranuclear palsy, in accordance with pathological evidence. Further
work is needed to clarify the pathological correlates of MRI ﬁndings.
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